WHO ICTRP trial
A Phase 4, Single Arm, Open Label Study for the Efficacy and Safety of Prolia in…
ChiCTR2400085597 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400085597 |
|---|---|
| Public title | A Phase 4, Single Arm, Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China |
| Scientific title | A Phase 4, Single Arm, Open Label Study for the Efficacy and Safety of Prolia in Treatment of Male Subjects With Osteoporosis in Mainland China |
| Primary sponsor | The Sixth People‘s Hospital of Shanghai |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Male osteoporosis |
| Interventions | Experimental group:Prolia |
| Registration date | Jun 13, 2024 |
| Target size | Experimental group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: